Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.76 HKD
−3.74 B HKD
7.44 B HKD
956.50 M
About MICROPORT SCIENTIFIC CORPORATION
Sector
Industry
CEO
Zhao Hua Chang
Website
Headquarters
Shanghai
Founded
1998
FIGI
BBG0015NVM80
MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture, and distribution of medical devices. It operates through the following segments: Cardiovascular Devices Business, Orthopedics Devices Business, Cardiac Rhythm Management Business, Endovascular and Peripheral Vascular Devices Business, Neurovascular Devices Business, Surgical Devices Business, Heart Valve Business, Surgical Robot Devices Business, and Others. The Cardiovascular Devices Business segment offers integrated medical solutions for the treatment of coronary artery-related diseases, develops, manufactures, and commercializes coronary stents and related delivery systems, along with balloon catheters, passive accessories and active devices, in fulfilling the overall demands of doctors and patients worldwide. The Orthopedics Devices Business segment is involved in the total solutions for the treatment of orthopedic problems, with an extensive range of orthopedics products that include reconstructive joints, spine and trauma products, and other professional implants and instruments. The Cardiac Rhythm Management Business segment develops, manufactures, and markets of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, with products covering pacemakers, defibrillators, and cardiac resynchronization therapy devices. The Endovascular and Peripheral Vascular Devices Business segment focuses on providing integrated disease solutions for aortic and peripheral vascular diseases such as thoracic and abdominal aortic aneurysm, aortic dissection, atherosclerosis, and lower extremity arteriosclerotic occlusion. The Neurovascular Devices Business segment specializes in providing total solutions for the treatment of neurovascular diseases, including hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke, continuously focused on research and development, production and commercialization of neurovascular therapeutic and access devices. The Surgical Devices Business segment provides overall solutions for cardiac surgery and emergency life support. The Heart Valve Business segment includes sale, manufacture, research, and development of heart valve devices. The Surgical Robot Devices Business segment designs, develops, and commercializes innovative surgical robots. The company was founded by Zhao Hua Chang in 1998 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 853 is 6.43 HKD — it has increased by 0.16% in the past 24 hours. Watch MICROPORT SCIENTIFIC CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange MICROPORT SCIENTIFIC CORPORATION stocks are traded under the ticker 853.
853 stock hasn't changed in a week, the month change is a 1.26% rise, over the last year MICROPORT SCIENTIFIC CORPORATION has showed a −20.42% decrease.
We've gathered analysts' opinions on MICROPORT SCIENTIFIC CORPORATION future price: according to them, 853 price has a max estimate of 7.99 HKD and a min estimate of 6.39 HKD. Watch 853 chart and read a more detailed MICROPORT SCIENTIFIC CORPORATION stock forecast: see what analysts think of MICROPORT SCIENTIFIC CORPORATION and suggest that you do with its stocks.
853 stock is 3.60% volatile and has beta coefficient of 2.17. Track MICROPORT SCIENTIFIC CORPORATION stock price on the chart and check out the list of the most volatile stocks — is MICROPORT SCIENTIFIC CORPORATION there?
Today MICROPORT SCIENTIFIC CORPORATION has the market capitalization of 11.87 B, it has increased by 19.48% over the last week.
Yes, you can track MICROPORT SCIENTIFIC CORPORATION financials in yearly and quarterly reports right on TradingView.
MICROPORT SCIENTIFIC CORPORATION is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
853 net income for the last half-year is −757.13 M HKD, while the previous report showed −2.46 B HKD of net income which accounts for 69.26% change. Track more MICROPORT SCIENTIFIC CORPORATION financial stats to get the full picture.
As of Dec 18, 2024, the company has 8.23 K employees. See our rating of the largest employees — is MICROPORT SCIENTIFIC CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROPORT SCIENTIFIC CORPORATION EBITDA is −642.95 M HKD, and current EBITDA margin is −24.91%. See more stats in MICROPORT SCIENTIFIC CORPORATION financial statements.
Like other stocks, 853 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROPORT SCIENTIFIC CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROPORT SCIENTIFIC CORPORATION technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROPORT SCIENTIFIC CORPORATION stock shows the sell signal. See more of MICROPORT SCIENTIFIC CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.